$IQST
iQSTEL Inc Stock $iqst

$iqst Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000166357724000281 Filed on November 14, 2024

Income Statement

Concept	2024 Q4	2024 Q3	2023 Q4
Revenue		$54.25M	$47.25M
YoY Change		36.45%	67.88%
Cost Of Revenue		$52.23M	$45.61M
YoY Change		34.86%	57.27%
Gross Profit		$2.020M	$1.642M
YoY Change		96.39%	-292.36%
Gross Profit Margin		3.72%	3.48%
Selling, General & Admin			$1.345M
YoY Change			7.41%
% of Gross Profit			81.91%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization			$28.74K
YoY Change			-0.55%
% of Gross Profit			1.75%
Operating Expenses		$2.076M	$1.371M
YoY Change		116.8%	6.98%
Operating Profit		-$56.55K	$271.6K
YoY Change		-179.93%	-112.72%
Interest Expense			-$40.59K
YoY Change			-98.47%
% of Operating Profit			-14.94%
Other Income/Expense, Net		-$646.8K	-$88.29K
YoY Change		2503.63%	-509.32%
Pretax Income		-$703.4K	$55.12K
YoY Change		-1506.8%	-101.08%
Income Tax		$69.61K	$0.00
% Of Pretax Income			0.0%
Net Earnings		-$773.0K	-$124.1K
YoY Change		1146.52%	-97.51%
Net Earnings / Revenue		-1.42%	-0.26%
Basic Earnings Per Share
Diluted Earnings Per Share		-$0.01	$0.00
COMMON SHARES
Basic Shares Outstanding	186.2M shares	183.5M shares	171.5M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2024 Q3	2023 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments		$1.363M
YoY Change		2.5%
Cash & Equivalents	$2.125M	$1.363M
Short-Term Investments
Other Short-Term Assets		$759.1K
YoY Change		1494.64%
Inventory	$30.66K	$27.12K
Prepaid Expenses	$1.891M	$1.449M
Receivables	$14.98M	$12.54M
Other Receivables		$1.031M
Total Short-Term Assets	$19.66M	$15.72M
YoY Change	66.82%	144.22%
LONG-TERM ASSETS
Property, Plant & Equipment	$578.7K	$523.0K
YoY Change	24.99%	30.42%
Goodwill	$10.68M	$5.172M
YoY Change	106.43%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$992.0K	$641.8K
YoY Change	534.32%	45.81%
Total Long-Term Assets	$12.77M	$6.436M
YoY Change	101.62%	5.29%
TOTAL ASSETS
Total Short-Term Assets	$19.66M	$15.72M
Total Long-Term Assets	$12.77M	$6.436M
Total Assets	$32.44M	$22.16M
YoY Change	78.99%	76.55%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$8.757M	$2.966M
YoY Change	118.13%	31.56%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt		$101.9K
YoY Change		7.97%
Long-Term Debt Due	$3.232M	$752.6K
YoY Change	1178.59%	697.75%
Total Short-Term Liabilities	$24.07M	$13.84M
YoY Change	142.75%	114.53%
LONG-TERM LIABILITIES
Long-Term Debt		$99.10K
YoY Change		-8.37%
Other Long-Term Liabilities		$169.7K
YoY Change		10.05%
Total Long-Term Liabilities	$283.6K	$268.8K
YoY Change	14.85%	2.46%
TOTAL LIABILITIES
Total Short-Term Liabilities	$24.07M	$13.84M
Total Long-Term Liabilities	$283.6K	$268.8K
Total Liabilities	$24.35M	$13.73M
YoY Change	139.64%	104.53%
SHAREHOLDERS EQUITY
Retained Earnings	-$29.83M	-$26.08M
YoY Change	14.89%	6.45%
Common Stock	$357.2K	$172.1K
YoY Change	109.85%	6.52%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$8.089M	$8.424M
YoY Change
Total Liabilities & Shareholders Equity	$32.44M	$22.16M
YoY Change	78.99%	76.55%

Cashflow Statement

Concept	2024 Q3	2023 Q4
OPERATING ACTIVITIES
Net Income	-$773.0K	-$124.1K
YoY Change	1146.52%	-97.51%
Depreciation, Depletion And Amortization		$28.74K
YoY Change		-0.55%
Cash From Operating Activities		-$1.054M
YoY Change		281.59%
INVESTING ACTIVITIES
Capital Expenditures		$60.05K
YoY Change		134.75%
Acquisitions
YoY Change
Other Investing Activities		$67.49K
YoY Change		-190.35%
Cash From Investing Activities		$7.450K
YoY Change		-107.43%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		384.0K
YoY Change		-4.01%
NET CHANGE
Cash From Operating Activities		-1.054M
Cash From Investing Activities		7.450K
Cash From Financing Activities		384.0K
Net Change In Cash		-662.4K
YoY Change		-2912.65%
FREE CASH FLOW
Cash From Operating Activities		-$1.054M
Capital Expenditures		$60.05K
Free Cash Flow		-$1.114M
YoY Change		269.14%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001527702
	dei	Entity File Number EntityFileNumber	000-55984
	dei	Entity Registrant Name EntityRegistrantName	iQSTEL Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	45-2808620
	dei	Entity Address Address Line1 EntityAddressAddressLine1	300 Aragon Avenue
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 375
	dei	Entity Address City Or Town EntityAddressCityOrTown	Coral Gables
	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
	dei	Local Phone Number LocalPhoneNumber	951-8191
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	8045872	usd
	us-gaap	Gross Profit GrossProfit	5608725	usd
	us-gaap	Gross Profit GrossProfit	3029723	usd
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33134
	dei	City Area Code CityAreaCode	954
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	186176651	shares
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2125139	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1362668	usd
CY2024Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	14982958	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	12539774	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	30658	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	27121	usd
CY2024Q3	us-gaap	Loans And Leases Receivable Related Parties LoansAndLeasesReceivableRelatedParties	635715	usd
CY2023Q4	us-gaap	Loans And Leases Receivable Related Parties LoansAndLeasesReceivableRelatedParties	340515	usd
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1200000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1200000	shares
CY2024Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Derivative Liabilities DerivativeLiabilities		usd
CY2024Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1890516	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1449094	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	19664986	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	15719172	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	578734	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	522997	usd
CY2024Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	99592	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	99592	usd
CY2024Q3	us-gaap	Goodwill Goodwill	10677045	usd
CY2023Q4	us-gaap	Goodwill Goodwill	5172146	usd
CY2024Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	426755	usd
CY2024Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	992006	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	214991	usd
CY2024Q3	us-gaap	Assets Assets	32439118	usd
CY2023Q4	us-gaap	Assets Assets	22155653	usd
CY2024Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	8756934	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	2966279	usd
CY2024Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	6296717	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	9993585	usd
CY2024Q3	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	26613	usd
CY2023Q4	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	26613	usd
CY2024Q3	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	294484	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	3750	usd
CY2024Q3	us-gaap	Loans Payable Current LoansPayableCurrent	3232009	usd
CY2023Q4	us-gaap	Loans Payable Current LoansPayableCurrent	264988	usd
CY2024Q3	us-gaap	Other Loans Payable Current OtherLoansPayableCurrent	926069	usd
CY2023Q4	us-gaap	Other Loans Payable Current OtherLoansPayableCurrent	259447	usd
CY2024Q3	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	490022	usd
CY2024Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	3549946	usd
CY2023Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	330032	usd
CY2024Q3	us-gaap	Derivative Liabilities DerivativeLiabilities	277946	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	24066234	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	13840944	usd
CY2023Q4	us-gaap	Loans Payable To Bank LoansPayableToBank	99099	usd
CY2024Q3	us-gaap	Accrued Employee Benefits Current And Noncurrent AccruedEmployeeBenefitsCurrentAndNoncurrent	283586	usd
CY2023Q4	us-gaap	Accrued Employee Benefits Current And Noncurrent AccruedEmployeeBenefitsCurrentAndNoncurrent	169738	usd
CY2024Q3	us-gaap	Liabilities Liabilities	24349820	usd
CY2023Q4	us-gaap	Liabilities Liabilities	14109781	usd
CY2023Q4	us-gaap	Asset Acquisition Contingent Consideration Liability AssetAcquisitionContingentConsiderationLiability		usd
CY2024Q3	us-gaap	Loans Payable To Bank LoansPayableToBank		usd
CY2023Q3	us-gaap	Debtor Reorganization Items Gain Loss On Settlement Of Other Claims Net1 DebtorReorganizationItemsGainLossOnSettlementOfOtherClaimsNet1		usd
	us-gaap	Debtor Reorganization Items Gain Loss On Settlement Of Other Claims Net1 DebtorReorganizationItemsGainLossOnSettlementOfOtherClaimsNet1		usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2024Q3	us-gaap	Dividends Preferred Stock DividendsPreferredStock		usd
	us-gaap	Dividends Preferred Stock DividendsPreferredStock		usd
CY2024Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToNoncontrollingInterest		usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToNoncontrollingInterest		usd
CY2023Q3	IQST	Stock Issued During Period Value Series B Preferred Issued As Dividend StockIssuedDuringPeriodValueSeriesBPreferredIssuedAsDividend		usd
	us-gaap	Debtor Reorganization Items Gain Loss On Settlement Of Other Claims Net1 DebtorReorganizationItemsGainLossOnSettlementOfOtherClaimsNet1		usd
	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties		usd
	us-gaap	Asset Acquisition Consideration Transferred Other Assets AssetAcquisitionConsiderationTransferredOtherAssets		usd
	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets		usd
	us-gaap	Payments To Fund Longterm Loans To Related Parties PaymentsToFundLongtermLoansToRelatedParties		usd
	us-gaap	Increase Decrease In Notes Payable Related Parties IncreaseDecreaseInNotesPayableRelatedParties		usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt		usd
	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt		usd
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity		usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	IQST	Series B Preferred Stock Issued As Dividend SeriesBPreferredStockIssuedAsDividend		usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities		usd
	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther		shares
	IQST	Common Stock Issued For Settlement Of Debt Value1 CommonStockIssuedForSettlementOfDebtValue1		usd
	IQST	Cashless Warrants Exercised CashlessWarrantsExercised		usd
	IQST	Note Payable Issued For Acquisition Of Subsidiary NotePayableIssuedForAcquisitionOfSubsidiary		usd
	IQST	Contingent Liability For Acquisition Of Subsidiary ContingentLiabilityForAcquisitionOfSubsidiary		usd
CY2024Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent		usd
CY2024Q3	us-gaap	Long Term Loans Payable LongTermLoansPayable		usd
CY2023Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable		usd
CY2024Q3	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable		usd
CY2023Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable		usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber		shares
CY2023Q4	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures		shares
	IQST	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms Of Forfeited ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTermsOfForfeited
CY2023Q4	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet		usd
	dei	Document Type DocumentType	10-Q
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	426755	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	39012	usd
CY2024Q3	us-gaap	Asset Acquisition Contingent Consideration Liability AssetAcquisitionContingentConsiderationLiability	1000000	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	186176651	shares
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	186176651	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	172129630	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	172129630	shares
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	186176	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	172130	usd
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	37231686	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	34360884	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-29825840	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-26084133	usd
CY2024Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-25340	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-25340	usd
CY2024Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	7566723	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	8423582	usd
CY2024Q3	us-gaap	Minority Interest MinorityInterest	-522575	usd
CY2023Q4	us-gaap	Minority Interest MinorityInterest	377710	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	8089298	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	32439118	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	22155653	usd
CY2024Q3	us-gaap	Revenues Revenues	54249614	usd
CY2023Q3	us-gaap	Revenues Revenues	39757203	usd
	us-gaap	Revenues Revenues	184346412	usd
	us-gaap	Revenues Revenues	97248561	usd
CY2024Q3	us-gaap	Cost Of Revenue CostOfRevenue	52229695	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	38728682	usd
	us-gaap	Cost Of Revenue CostOfRevenue	178737687	usd
	us-gaap	Cost Of Revenue CostOfRevenue	94218838	usd
CY2024Q3	us-gaap	Gross Profit GrossProfit	2019919	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	1028521	usd
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2076472	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	957768	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6144677	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3529218	usd
CY2024Q3	us-gaap	Operating Expenses OperatingExpenses	2076472	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	957768	usd
	us-gaap	Operating Expenses OperatingExpenses	6144677	usd
	us-gaap	Operating Expenses OperatingExpenses	3529218	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-56553	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	70753	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-535952	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-499495	usd
CY2024Q3	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	7006	usd
CY2023Q3	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	2607	usd
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	88151	usd
	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	3126	usd
CY2024Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-5770	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-32505	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-6620	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-105714	usd
CY2024Q3	IQST	Interest Expense2 InterestExpense2	672266	usd
CY2023Q3	IQST	Interest Expense2 InterestExpense2	34219	usd
	IQST	Interest Expense2 InterestExpense2	1533820	usd
	IQST	Interest Expense2 InterestExpense2	54322	usd
CY2024Q3	IQST	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss1 FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss1	51721	usd
CY2023Q3	IQST	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss1 FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss1	39273	usd
	IQST	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss1 FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss1	-1063789	usd
	IQST	Fair Value Net Derivative Asset Liability Measured On Recurring Basis Change In Unrealized Gain Loss1 FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss1	381848	usd
CY2024Q3	us-gaap	Debtor Reorganization Items Gain Loss On Settlement Of Other Claims Net1 DebtorReorganizationItemsGainLossOnSettlementOfOtherClaimsNet1	-27537	usd
	us-gaap	Debtor Reorganization Items Gain Loss On Settlement Of Other Claims Net1 DebtorReorganizationItemsGainLossOnSettlementOfOtherClaimsNet1	-130197	usd
CY2024Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-646846	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-24844	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2646275	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	224938	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-703399	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	45909	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3182227	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-274557	usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	69605	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	134880	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-773004	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	45909	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3317107	usd
	us-gaap	Net Income Loss NetIncomeLoss	-274557	usd
CY2024Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	150784	usd
CY2023Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	107922	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	424600	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	364586	usd
CY2024Q3	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-923788	usd
CY2023Q3	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-62013	usd
	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-3741707	usd
	us-gaap	Net Income Loss Attributable To Parent Diluted NetIncomeLossAttributableToParentDiluted	-639143	usd
CY2023Q3	us-gaap	Dividends Preferred Stock DividendsPreferredStock	-816480	usd
	us-gaap	Dividends Preferred Stock DividendsPreferredStock	-816480	usd
CY2024Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-923788	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-878493	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3741707	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1455623	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-773004	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	45909	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3317107	usd
	us-gaap	Net Income Loss NetIncomeLoss	-274557	usd
CY2023Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToNoncontrollingInterest	4428	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Noncontrolling Interest OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToNoncontrollingInterest	-142	usd
CY2024Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-773004	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	41481	usd
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-3317107	usd
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-274415	usd
CY2024Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	150784	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	105753	usd
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	424600	usd
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	364656	usd
CY2024Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-923788	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-64272	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-3741707	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-639071	usd
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2024Q3	IQST	Weighted Average Number Of Share Outstanding Basic WeightedAverageNumberOfShareOutstandingBasic	184284588	shares
CY2023Q3	IQST	Weighted Average Number Of Share Outstanding Basic WeightedAverageNumberOfShareOutstandingBasic	168185122	shares
	IQST	Weighted Average Number Of Share Outstanding Basic WeightedAverageNumberOfShareOutstandingBasic	179312685	shares
	IQST	Weighted Average Number Of Share Outstanding Basic WeightedAverageNumberOfShareOutstandingBasic	165640341	shares
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	8045872	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	31065	usd
CY2024Q1	IQST	Common Stock Issued For Settlement Of Debt Value1 CommonStockIssuedForSettlementOfDebtValue1	279660	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	597777	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-580216	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	8374158	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	46600	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	400000	usd
CY2024Q2	IQST	Resolution Of Derivative Liabilities Value ResolutionOfDerivativeLiabilitiesValue	239323	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	475685	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-1963887	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	7571879	usd
CY2024Q3	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	337083	usd
CY2024Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	31820	usd
CY2024Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	175000	usd
CY2024Q3	IQST	Common Stock Payable Value CommonStockPayableValue	100000	usd
CY2024Q3	IQST	Resolution Of Derivative Liabilities Value ResolutionOfDerivativeLiabilitiesValue	646520	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-773004	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	8089298	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	5835417	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	400000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	11230	usd
CY2023Q1	IQST	Resolution Of Derivative Liabilities Value ResolutionOfDerivativeLiabilitiesValue	240258	usd
CY2023Q1	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	1577	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-158822	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	6329660	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	6900	usd
CY2023Q2	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	2993	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-161644	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	6177909	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	12815	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	1000000	usd
CY2023Q3	IQST	Resolution Of Derivative Liabilities Value ResolutionOfDerivativeLiabilitiesValue	735681	usd
CY2023Q3	IQST	Dividend To Non Controlling Interest DividendToNonControllingInterest	-5050	usd
CY2023Q3	us-gaap	Temporary Equity Foreign Currency Translation Adjustments TemporaryEquityForeignCurrencyTranslationAdjustments	-4428	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	45909	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	7962836	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3317107	usd
	us-gaap	Net Income Loss NetIncomeLoss	-274557	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	109485	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	30945	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1801	usd
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1344	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	104061	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	103246	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	856922	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	21404	usd
	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	1063789	usd
	us-gaap	Increase Decrease In Derivative Liabilities IncreaseDecreaseInDerivativeLiabilities	-381848	usd
	us-gaap	Debtor Reorganization Items Gain Loss On Settlement Of Other Claims Net1 DebtorReorganizationItemsGainLossOnSettlementOfOtherClaimsNet1	-130197	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-11789409	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3422703	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3537	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	997	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	434217	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1057311	usd
	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	-69948	usd
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-8331945	usd
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	2604856	usd
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-4495509	usd
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	1870972	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2526651	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-434701	usd
	us-gaap	Asset Acquisition Consideration Transferred Other Assets AssetAcquisitionConsiderationTransferredOtherAssets	2730121	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	134016	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	164715	usd
	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	-189767	usd
	us-gaap	Payments To Fund Longterm Loans To Related Parties PaymentsToFundLongtermLoansToRelatedParties	119832	usd
	us-gaap	Proceeds From Payments For Long Term Loans For Related Parties ProceedsFromPaymentsForLongTermLoansForRelatedParties	33602	usd
	us-gaap	Proceeds From Payments For Long Term Loans For Related Parties ProceedsFromPaymentsForLongTermLoansForRelatedParties	13899	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2950367	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-340583	usd
	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	2011100	usd
	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	150000	usd
	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	669121	usd
	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	9006	usd
	us-gaap	Increase Decrease In Notes Payable Related Parties IncreaseDecreaseInNotesPayableRelatedParties	1000000	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	-333378	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	575000	usd
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1150000	usd
	us-gaap	Proceeds From Issuance Of Other Long Term Debt ProceedsFromIssuanceOfOtherLongTermDebt	100000	usd
	us-gaap	Proceeds From Issuance Of Medium Term Notes ProceedsFromIssuanceOfMediumTermNotes	3997500	usd
	us-gaap	Proceeds From Issuance Of Medium Term Notes ProceedsFromIssuanceOfMediumTermNotes	250000	usd
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	100000	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	-541612	usd
	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	-86238	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6239489	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1454756	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-7541	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	762471	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	671931	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1362668	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1329389	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2125139	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2001320	usd
	us-gaap	Interest Paid Net InterestPaidNet	480431	usd
	us-gaap	Interest Paid Net InterestPaidNet	25941	usd
	IQST	Series B Preferred Stock Issued As Dividend SeriesBPreferredStockIssuedAsDividend	816480	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	597777	usd
	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	337083	shares
	IQST	Common Stock Issued For Settlement Of Debt Value1 CommonStockIssuedForSettlementOfDebtValue1	279660	usd
	IQST	Cashless Warrants Exercised CashlessWarrantsExercised	1815	usd
	IQST	Resolution Of Derivative Liabilities Value ResolutionOfDerivativeLiabilitiesValue	885843	usd
	IQST	Resolution Of Derivative Liabilities Value ResolutionOfDerivativeLiabilitiesValue	975939	usd
	IQST	Note Payable Issued For Acquisition Of Subsidiary NotePayableIssuedForAcquisitionOfSubsidiary	2000000	usd
	IQST	Contingent Liability For Acquisition Of Subsidiary ContingentLiabilityForAcquisitionOfSubsidiary	1000000	usd
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	2011-06-24
	us-gaap	Reclassifications Reclassifications	<p id="xdx_84D_eus-gaap--Reclassifications_zhMBzSZW75fg" style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 10pt; text-align: justify"><b><i>Reclassification</i></b></p> <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 10pt; text-align: justify"> </p> <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 10pt; text-align: justify">Certain accounts from prior periods have been reclassified to conform to the current period presentation.</p> <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 10pt; text-align: justify"> </p>
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84C_eus-gaap--UseOfEstimates_ziQZix3ncg3e" style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 10pt; text-align: justify"><b><i>Use of Estimates</i></b></p> <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 10pt; text-align: justify"> </p> <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 10pt; text-align: justify">The preparation of the consolidated financial statements in conformity with GAAP in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements. The estimates and judgments will also affect the reported amounts for certain revenues and expenses during the reporting period. Actual results could differ from these good faith estimates and judgments.</p> <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0 10pt; text-align: justify"> </p>
CY2024Q3	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	2125139	usd
CY2023Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	1362668	usd
	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	1801	usd
	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	1344	usd
CY2024Q3	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	127569	usd
CY2023Q4	us-gaap	Accounts And Other Receivables Net Current AccountsAndOtherReceivablesNetCurrent	312116	usd
CY2024Q3	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	1203450	usd
CY2023Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	738050	usd
CY2024Q3	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases	21000	usd
CY2023Q4	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases	21000	usd
CY2024Q3	us-gaap	Income Tax Receivable IncomeTaxReceivable	52294	usd
CY2023Q4	us-gaap	Income Tax Receivable IncomeTaxReceivable	428	usd
CY2024Q3	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents	357500	usd
CY2023Q4	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents	357500	usd
CY2024Q3	us-gaap	Security Deposit SecurityDeposit	128703	usd
CY2023Q4	us-gaap	Security Deposit SecurityDeposit	20000	usd
CY2024Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1890516	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1449094	usd
CY2024Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1538491	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1323432	usd
CY2024Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	959757	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	800435	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	578734	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	522997	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	104061	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	103246	usd
CY2024Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	3526493	usd
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	367837	usd
CY2024Q3	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	294484	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	3750	usd
CY2024Q3	us-gaap	Long Term Debt LongTermDebt	3232009	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	364087	usd
CY2024Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	3232009	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	264988	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	99099	usd
	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	669121	usd
	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	9006	usd
CY2024Q3	us-gaap	Loans Payable LoansPayable	926069	usd
CY2023Q4	us-gaap	Loans Payable LoansPayable	259447	usd
CY2024Q3	us-gaap	Other Loans Payable Current OtherLoansPayableCurrent	926069	usd
CY2023Q4	us-gaap	Other Loans Payable Current OtherLoansPayableCurrent	259447	usd
CY2024Q3	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	4039968	usd
CY2023Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	369044	usd
CY2024Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	3549946	usd
CY2023Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	330032	usd
CY2024Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	3549946	usd
CY2023Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	330032	usd
	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	333333	usd
	IQST	Debt Conversion Converted Instrument Fee DebtConversionConvertedInstrumentFee	3750	usd
	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	3064394	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	300000000	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	14047021	shares
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	186176651	shares
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	186176651	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	172129630	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	172129630	shares
	IQST	Proceeds From Issuance Of Unissued Common Stock ProceedsFromIssuanceOfUnissuedCommonStock	100000	usd
CY2024Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	171061	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	71061	usd
CY2024Q3	us-gaap	Common Stock Shares Subscribed But Unissued CommonStockSharesSubscribedButUnissued	2586452	shares
CY2023Q4	us-gaap	Common Stock Shares Subscribed But Unissued CommonStockSharesSubscribedButUnissued	136452	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1200000	shares
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q3	us-gaap	Loans And Leases Receivable Related Parties LoansAndLeasesReceivableRelatedParties	635715	usd
CY2023Q4	us-gaap	Loans And Leases Receivable Related Parties LoansAndLeasesReceivableRelatedParties	340515	usd
CY2023Q4	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	26613	usd
	us-gaap	Management Fee Expense ManagementFeeExpense	634500	usd
	us-gaap	Management Fee Expense ManagementFeeExpense	402000	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	109485	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	30945	usd
CY2024Q3	us-gaap	Financial Guarantee Insurance Contracts Risk Management Activities Mitigating Claim Liabilities Accrued Liabilities FinancialGuaranteeInsuranceContractsRiskManagementActivitiesMitigatingClaimLiabilitiesAccruedLiabilities	316448	usd
CY2023Q4	us-gaap	Financial Guarantee Insurance Contracts Risk Management Activities Mitigating Claim Liabilities Accrued Liabilities FinancialGuaranteeInsuranceContractsRiskManagementActivitiesMitigatingClaimLiabilitiesAccruedLiabilities	100128	usd
CY2024Q3	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P12M
	us-gaap	Operating Lease Expense OperatingLeaseExpense	21335	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	4048	usd
CY2024Q3	us-gaap	Revenues Revenues	54249614	usd
CY2024Q3	us-gaap	Cost Of Revenue CostOfRevenue	52229695	usd
CY2024Q3	us-gaap	Gross Profit GrossProfit	2019919	usd
CY2024Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2076472	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-56553	usd
CY2024Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-646846	usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	69605	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-773004	usd
CY2023Q3	us-gaap	Revenues Revenues	39757203	usd
CY2023Q3	us-gaap	Cost Of Revenue CostOfRevenue	38728682	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	1028521	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	957768	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	70753	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-24844	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	45909	usd
	us-gaap	Revenues Revenues	184346412	usd
	us-gaap	Cost Of Revenue CostOfRevenue	178737687	usd
	us-gaap	Gross Profit GrossProfit	5608725	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6144677	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-535952	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2646275	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	134880	usd
	us-gaap	Net Income Loss NetIncomeLoss	-3317107	usd
	us-gaap	Revenues Revenues	97248561	usd
	us-gaap	Cost Of Revenue CostOfRevenue	94218838	usd
	us-gaap	Gross Profit GrossProfit	3029723	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3529218	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-499495	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	224938	usd
	us-gaap	Net Income Loss NetIncomeLoss	-274557	usd
	IQST	Asset Information By Geographic Segment AssetInformationByGeographicSegment	<p id="xdx_895_ecustom--AssetInformationByGeographicSegment_zZk9gW2oajil" style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt 10pt; text-align: justify"><span id="xdx_8B3_zuKphjiWSVs" style="display: none">NOTE 12 - SEGMENT - Schedule of Asset Information by Geographic Segment</span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 90%; margin-right: auto"> <tr> <td> </td> <td> </td> <td> </td> <td id="xdx_497_20240930__us-gaap--StatementBusinessSegmentsAxis__custom--USAMember_zTHpyFvbQWo6"> </td> <td> </td> <td> </td> <td> </td> <td id="xdx_494_20240930__us-gaap--StatementBusinessSegmentsAxis__custom--SwitzerlandMember_zLoqYiulecG2"> </td> <td> </td> <td> </td> <td> </td> <td id="xdx_495_20240930__us-gaap--StatementBusinessSegmentsAxis__custom--UnitedKingdomMember_zccPiCqXDuIg"> </td> <td> </td> <td> </td> <td> </td> <td id="xdx_495_20240930__us-gaap--StatementBusinessSegmentsAxis__custom--EliminationMember_zyCtg0qkxb79"> </td> <td> </td> <td> </td> <td> </td> <td id="xdx_491_20240930_zSsWGG4lM9Gk"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font-weight: bold">September 30, 2024</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">USA</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Switzerland</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">UK</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Elimination</td><td style="font-weight: bold; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total</td></tr> <tr id="xdx_401_eus-gaap--AssetsAbstract_iB_zAGc4gPKOYji" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 5.4pt">Assets</td><td style="font-size: 11pt"> </td> <td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt; text-align: right"> </td><td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt"> </td> <td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt; text-align: right"> </td><td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt"> </td> <td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt; text-align: right"> </td><td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt"> </td> <td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt; text-align: right"> </td><td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt"> </td> <td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt; text-align: right"> </td><td style="font-size: 11pt; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--AssetsCurrent_i01I_zruHW4ap5NDa" style="vertical-align: bottom; background-color: White"> <td style="width: 35%; text-align: left; text-indent: 10pt; padding-left: 5.4pt">Current assets</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">8,735,079</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">850,772</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">10,792,038</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(712,903</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">19,664,986</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--AssetsNoncurrent_i01I_zt5vS5aMZw6c" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: 10pt; padding-left: 5.4pt">Non-current assets</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">23,373,710</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">830,653</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">754,331</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(12,184,562</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">12,774,132</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--LiabilitiesAbstract_iB_zr8S21iw7X68" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 5.4pt">Liabilities</td><td style="font-size: 11pt"> </td> <td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt; text-align: right"> </td><td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt"> </td> <td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt; text-align: right"> </td><td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt"> </td> <td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt; text-align: right"> </td><td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt"> </td> <td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt; text-align: right"> </td><td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt"> </td> <td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt; text-align: right"> </td><td style="font-size: 11pt; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--LiabilitiesCurrent_i01I_zRHNI0w35kn7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: 10pt; padding-left: 5.4pt">Current liabilities</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">13,130,629</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">1,705,110</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">9,943,398</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(712,903</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">24,066,234</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--LiabilitiesNoncurrent_i01I_zEXm1ngZJNMj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: 10pt; padding-left: 5.4pt">Non-current liabilities</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">139</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">169,599</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">113,848</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1638">—</span> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">283,586</td><td style="text-align: left"> </td></tr> </table> <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 80%; margin-right: auto"> <tr> <td> </td> <td> </td> <td> </td> <td id="xdx_49B_20231231__us-gaap--StatementBusinessSegmentsAxis__custom--USAMember_z5s4qC2zHNf5"> </td> <td> </td> <td> </td> <td> </td> <td id="xdx_49F_20231231__us-gaap--StatementBusinessSegmentsAxis__custom--SwitzerlandMember_z6ep7fcCrZaj"> </td> <td> </td> <td> </td> <td> </td> <td id="xdx_49A_20231231__us-gaap--StatementBusinessSegmentsAxis__custom--EliminationMember_zZdzsxWJiFFa"> </td> <td> </td> <td> </td> <td> </td> <td id="xdx_495_20231231_zWOpxORlarm"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: justify">December 31, 2023</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">USA</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Switzerland</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Elimination</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td colspan="3" style="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Total</td></tr> <tr id="xdx_401_eus-gaap--AssetsAbstract_iB_zl4mkYGp12x5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 5.4pt">Assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--AssetsCurrent_i01I_zyLYlPHprnhl" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: 10pt; padding-left: 5.4pt; width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current assets</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">14,537,969</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,874,627</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(693,424</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15,719,172</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_406_eus-gaap--AssetsNoncurrent_i01I_zgBQMdh5zQ0e" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: 10pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-current assets</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,810,606</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">810,437</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6,184,562</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,436,481</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40C_eus-gaap--LiabilitiesAbstract_iB_zzPHimDZVUQd" style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-left: 5.4pt">Liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--LiabilitiesCurrent_i01I_zxvsR9qz4eGg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: 10pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11,978,244</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,556,124</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(693,424</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,840,944</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40F_eus-gaap--LiabilitiesNoncurrent_i01I_zUyZGD2pldDe" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; text-indent: 10pt; padding-left: 5.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-current liabilities</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">139</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">268,698</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1668">—</span> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">268,837</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table>
CY2024Q3	us-gaap	Assets Current AssetsCurrent	19664986	usd
CY2024Q3	us-gaap	Assets Noncurrent AssetsNoncurrent	12774132	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	24066234	usd
CY2024Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	283586	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	15719172	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	6436481	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	13840944	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	268837	usd
	us-gaap	Derivatives Reporting Of Derivative Activity DerivativesReportingOfDerivativeActivity	<p id="xdx_80B_eus-gaap--DerivativesReportingOfDerivativeActivity_zlhCvEFriJcb" style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt 10pt; text-align: justify"><b>NOTE 13 – WARRANTS</b></p> <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt 10pt; text-align: justify"> </p> <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt 10pt; text-align: justify">On February 12, 2024, we issued a Common Stock Purchase Option (the “Option”) to ADI Funding LLC (“ADI Funding”) for <span id="xdx_90F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iI_c20240212__us-gaap--DebtInstrumentAxis__custom--ADIFundingLLCMember_zZBocyMQ772">$100,000</span> that expires on December 31, 2024, for the right to acquire up to <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20240212__20240212__us-gaap--DebtInstrumentAxis__custom--ADIFundingLLCMember_zvAvXXKGMo3c">10,000,000</span> shares of common stock. <span id="xdx_905_eus-gaap--DebtInstrumentCallFeature_c20240212__20240212__us-gaap--DebtInstrumentAxis__custom--ADIFundingLLCMember_zQrDKx1jiZRf">The exercise price per share of the common stock under the Option shall be (i) 70% of the VWAP of the common stock during the then 10 Trading Days immediately preceding, but not including the date of exercise if the VWAP is below $2.00 or (ii) seventy five percent (75%) of the VWAP of the common stock during the then 10 Trading Days immediately preceding, but not including the date of exercise if the VWAP is equal or above $2.00</span>.</p> <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt 10pt; text-align: justify"> </p> <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt 10pt; text-align: justify"><span id="xdx_903_eus-gaap--OptionIndexedToIssuersEquitySettlementAlternatives_c20240212__20240212__us-gaap--DebtInstrumentAxis__custom--ADIFundingLLCMember_zY1IghCP7QD3">ADI Funding has the right and the obligation to exercise, on a “cash basis”, not less than (i) 2,000,000 of the shares of common stock underlying the option not later than the later of March 31, 2024 or the date on which there is an effective registration statement permitting the resale of the shares by ADI Funding. From and after the occurrence of the above-referenced exercise, each additional exercise of the Option shall be in an amount not less than 1,000,000 shares, which shall occur every thirty (30) days and shall be exercised only on a cash basis. ADI Funding’s obligation to exercise each specified portion of the Option is subject to the exercise price being not less than $0.11</span></p> <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt 10pt; text-align: justify"> </p> <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt 10pt; text-align: justify"> </p> <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt 10pt; text-align: justify"></p> <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt 10pt; text-align: justify">If the Company issues securities less than the exercise price of the option, ADI Funding has a right to also use that lesser price in the exercise of its Option. The Option also contains rights to any Company distributions and consideration in fundamental transactions.</p> <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt 10pt; text-align: justify"> </p> <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt 10pt; text-align: justify">The Company accounts for warrants as either equity-classified or liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in FASB ASC 480, <i>Distinguishing Liabilities from Equity</i> (“ASC 480”) and ASC 815, <i>Derivatives and Hedging</i> (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own common shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.</p> <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt 10pt; text-align: justify"> </p> <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt 10pt; text-align: justify">The Company determined that the warrants had net cash settlement and categorized the warrants as a liability in the accompanying consolidated financial statements.</p> <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt 10pt; text-align: justify"> </p> <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt 10pt; text-align: justify">A summary of activity regarding warrants issued as follows:</p> <table cellpadding="0" cellspacing="0" id="xdx_880_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_z92jviR5kVp9" style="font: 11pt Calibri, Helvetica, Sans-Serif; margin-left: auto; border-collapse: collapse; width: 70%; margin-right: auto" summary="xdx: Disclosure - NOTE 13 - WARRANTS - Schedule of Warrant Summary (Details)"> <tr> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: left"><b> </b></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><b> </b></td> <td colspan="7" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><b>Warrants Outstanding</b></td><td style="padding-bottom: 1pt"><b> </b></td> <td colspan="2"><b> </b></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: left"><b> </b></td><td><b> </b></td> <td colspan="3"><b> </b></td><td style="font: 10pt Times New Roman, Times, Serif"><b> </b></td> <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><b>Weighted Average</b></td><td style="font: 10pt Times New Roman, Times, Serif"><b> </b></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><b>Weighted Average Remaining</b></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: left"><b> </b></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><b> </b></td> <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><b>Shares</b></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><b> </b></td> <td colspan="3" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><b>Exercise Price</b></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><b> </b></td> <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><b>Contractual life (in years)</b></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: left"> </td><td> </td> <td colspan="3"> </td><td> </td> <td colspan="3"> </td><td> </td> <td colspan="2"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding, December 31, 2023</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20231231_z1gkNL3Hd8t4"><span style="-sec-ix-hidden: xdx2ixbrl1678">—</span></span> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_d0_c20231231_zo92bgv8fqsl">—</span> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_d0_c20231231_zsmjy1feHgU"><span style="-sec-ix-hidden: xdx2ixbrl1680">—</span></span> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 22%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Granted</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 5%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 19%; text-align: right"><span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20240101__20240930_zTwaQRVAe3Q3">10,000,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 5%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 19%; text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_d0_c20240101__20240930_zSLtnd749oc9">0.88</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 5%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 19%; text-align: right"><span id="xdx_90C_ecustom--WeightedAverageRemainingLifeOfWarrantsGrantedInPeriod_pp2p2_dtY_c20240101__20240930_zXsNAu4fu8c4">0.88</span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exercised</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(<span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_c20240101__20240930_znhcTPKWqxth">5,227,273</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_d0_c20240101__20240930_z0We4XViPyle">0.11</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms_dtY_c20240101__20240930_z88MclgrMd31"><span style="-sec-ix-hidden: xdx2ixbrl1686">—</span></span> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forfeited/canceled</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_c20240101__20240930_zGLFnb0NHSi1"><span style="-sec-ix-hidden: xdx2ixbrl1687">—</span></span> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue_d0_c20240101__20240930_zZI8azeFVpga">—</span> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTermsOfForfeited_d0_c20240101__20240930_zwkM7fMRKrel"><span style="-sec-ix-hidden: xdx2ixbrl1689">—</span></span> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Outstanding, September 30, 2024</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_903_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iI_c20240930_zggRVGL5Pt33">4,772,727</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_901_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_iI_d0_c20240930_zfAmMbVy1Ata">0.11</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90D_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_pp2p2_dtY_c20240930_zZo9dU9mAUlh">0.25</span></td></tr> </table> <p style="margin-top: 0; margin-bottom: 0"></p> <p style="margin-top: 0; margin-bottom: 0"> </p> <p style="margin-top: 0; margin-bottom: 0"></p> <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt 10pt; text-align: justify">The intrinsic value of the warrants as of September 30, 2024 is approximately <span id="xdx_90B_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding_iI_c20240930_zp8q43eseNdb">$253,000</span>. All of the outstanding warrants are exercisable as of September 30, 2024; however, each exercise is subject to a beneficial ownership limitation of <span id="xdx_909_eus-gaap--VariableInterestEntityOwnershipPercentage_c20240101__20240930_zPa4061YO59a">4.99%</span> of the Company’s outstanding common stock, which, upon notice, may be increased to <span id="xdx_90A_eus-gaap--VariableInterestEntityOwnershipPercentage_c20240101__20240930__us-gaap--DebtInstrumentAxis__custom--BeneficialOwnershipLimitationUponNoticeMember_zIbaJHZxhnhd">9.99%</span>.</p> <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt 10pt; text-align: justify"> </p> <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt 10pt; text-align: justify"><i>Fair Value Assumptions Used in Accounting for Derivative Liabilities</i></p> <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt 10pt; text-align: justify"> </p> <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt 10pt; text-align: justify">ASC 815 requires we assess the fair market value of derivative liabilities at the end of each reporting period and recognize any change in the fair market value as other income or expense.</p> <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt 10pt; text-align: justify"> </p> <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt 10pt; text-align: justify">The Company determined our derivative liabilities to be a Level 3 fair value measurement and used the Black-Scholes pricing model to calculate the fair value as of September 30, 2024. The Black-Scholes model requires six basic data inputs: the exercise or strike price, time to expiration, the risk-free interest rate, the current stock price, the estimated volatility of the stock price in the future, and the dividend rate. Changes to these inputs could produce a significantly higher or lower fair value measurement. </p> <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt 10pt; text-align: justify"> </p> <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt 10pt; text-align: justify"> </p> <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt 10pt; text-align: justify"></p> <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt 10pt; text-align: justify">As of September 30, 2024, the estimated fair values of the liabilities measured on a recurring basis are as follows:</p> <table cellpadding="0" cellspacing="0" id="xdx_884_eus-gaap--FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_zBehjVOO5Oyj" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 40%; margin-right: auto" summary="xdx: Disclosure - NOTE 13 - WARRANTS - Schedule of Fair Value Measurement of Liabilities (Details)"> <tr> <td> </td> <td> </td> <td> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 50%; text-align: left; padding-left: 5.4pt">Expected term</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 48%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_900_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240930__20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__srt--MinimumMember_z3J2tVxPN8y">0.25</span> - <span id="xdx_90F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dtY_c20240930__20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__srt--MaximumMember_zr0M4vOICknk">0.65</span> years </span></td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 5.4pt">Expected average volatility</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_90B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_c20240930__20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__srt--MinimumMember_zzebYFToNrR4">78%</span> - <span id="xdx_906_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_c20240930__20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__srt--MaximumMember_zZOZfPQf4kY6">118%</span> </span></td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 5.4pt">Expected dividend yield</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">— </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 5.4pt">Risk-free interest rate</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_c20240930__20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__srt--MinimumMember_zlT9ftOI0bi8">4.73%</span> - <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_c20240930__20240930__us-gaap--ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeAxis__srt--MaximumMember_zt78sdNdT545">5.44%</span> </span></td></tr> </table> <p style="margin-top: 0; margin-bottom: 0"></p> <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0pt 10pt; text-align: justify">The following table summarizes the changes in the derivative liabilities during the nine months ended September 30, 2024:</p> <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_88F_eus-gaap--FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock_zk4unjkukX8" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto" summary="xdx: Disclosure - NOTE 13 - WARRANTS - Fair Value Measurements Using Significant Observable Inputs (Details)"> <tr style="vertical-align: bottom"> <td colspan="5" style="border-bottom: Black 1pt solid; text-align: center"><b>Fair Value Measurements Using Significant Observable Inputs (Level 3)</b></td></tr> <tr style="vertical-align: bottom"> <td style="font-size: 11pt"> </td><td style="font-size: 11pt"> </td> <td colspan="3" style="font-size: 11pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 5.4pt">Balance - December 31, 2023</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span id="xdx_904_eus-gaap--DerivativeFairValueOfDerivativeNet_iI_pp0p0_c20231231_z6XgEL1TCSY8"><span style="-sec-ix-hidden: xdx2ixbrl1706">—</span></span> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="font-size: 11pt; padding-left: 5.4pt"> </td><td style="font-size: 11pt"> </td> <td style="font-size: 11pt; text-align: left"> </td><td style="font-size: 11pt; text-align: right"> </td><td style="font-size: 11pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 70%; text-align: left; padding-left: 5.4pt">Addition of new derivatives recognized as cash received</td><td style="width: 10%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 18%; text-align: right"><span id="xdx_900_eus-gaap--DebtorReorganizationItemsWriteOffOfDeferredFinancingCostsAndDebtDiscounts_c20240101__20240930_z6TyCYGW4efg">100,000</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-left: 5.4pt">Exercise on issuance of common stock</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(<span id="xdx_901_ecustom--ResolutionOfDerivativeLiabilitiesValue_pp0p0_c20240101__20240930_zJq0YcV7D8Cl">885,843</span></td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1pt; padding-left: 5.4pt">Change in fair value of the warrant</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"><span id="xdx_909_eus-gaap--DebtSecuritiesHeldToMaturityTransferDerivativeHedgeGainLoss_pp0p0_c20240101__20240930_zXmjj8DqxGUd">1,063,789</span></td><td style="padding-bottom: 1pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt; padding-left: 5.4pt">Balance - September 30, 2024</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right"><span id="xdx_909_eus-gaap--DerivativeFairValueOfDerivativeNet_iI_pp0p0_c20240930_zhYYUkAumSif">277,946</span></td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt/107% Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	10000000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.88
	IQST	Weighted Average Remaining Life Of Warrants Granted In Period WeightedAverageRemainingLifeOfWarrantsGrantedInPeriod	P0Y10M17D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	5227273	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.11
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue	0
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	4772727	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.11
CY2024Q3	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P0Y3M
CY2024Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	253000	usd
	us-gaap	Variable Interest Entity Ownership Percentage VariableInterestEntityOwnershipPercentage	0.0499	pure
	us-gaap	Debtor Reorganization Items Write Off Of Deferred Financing Costs And Debt Discounts DebtorReorganizationItemsWriteOffOfDeferredFinancingCostsAndDebtDiscounts	100000	usd
	IQST	Resolution Of Derivative Liabilities Value ResolutionOfDerivativeLiabilitiesValue	885843	usd
	us-gaap	Debt Securities Held To Maturity Transfer Derivative Hedge Gain Loss DebtSecuritiesHeldToMaturityTransferDerivativeHedgeGainLoss	1063789	usd
CY2024Q3	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet	277946	usd

Files In Submission

Name	View Source	Status
0001663577-24-000281-index-headers.html	Edgar Link	pending
0001663577-24-000281-index.html	Edgar Link	pending
0001663577-24-000281.txt	Edgar Link	pending
0001663577-24-000281-xbrl.zip	Edgar Link	pending
ex31_1.htm	Edgar Link	pending
ex31_2.htm	Edgar Link	pending
ex32_1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
iqst-20240930.xsd	Edgar Link	pending
iqst10q3_093024.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
iqst-20240930_cal.xml	Edgar Link	unprocessable
iqst-20240930_def.xml	Edgar Link	unprocessable
iqst-20240930_lab.xml	Edgar Link	unprocessable
iqst-20240930_pre.xml	Edgar Link	unprocessable
iqst10q3_093024_htm.xml	Edgar Link	completed
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$IQST
iQSTEL Inc Stock $iqst

2024 Q4 Form 10-Q Financial Statement

#000166357724000281 Filed on November 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IQST iQSTEL Inc Stock $iqst

2024 Q4 Form 10-Q Financial Statement

#000166357724000281 Filed on November 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IQST
iQSTEL Inc Stock $iqst